Treatment Efficacy of Neural Blockade in Specialized Palliative Care Services in Japan: A Multicenter Audit Survey

Journal of Pain and Symptom Management

Volumn 36, Issue 5, 2008, Pages 461-467

  Tei, Yo ^a   Morita, Tatsuya ^a   Nakaho, Toshimichi ^b   Takigawa, Chizuko ^c   Higuchi, Akiko ^d   Suga, Akihiko ^e   Tajima, Tsukasa ^f   Ikenaga, Masayuki ^g   Higuchi, Hitomi ^h   Shimoyama, Naohito ⁱ   Fujimoto, Mayumi ^j  

^a SEIREI MIKATAHARA GENERAL HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c Keiyukai Sapporo Hospital   (Japan)

^d TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^e SHIZUOKA GENERAL HOSPITAL   (Japan)

^f Miyagi Cancer Center   (Japan)

^g YODOGAWA CHRISTIAN HOSPITAL   (Japan)

^h SHOWA UNIVERSITY HOSPITAL   (Japan)

ⁱ NATIONAL CANCER CENTER HOSPITAL   (Japan)

^j HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

more..

Author keywords

neoplasm; Neural blockade; pain; palliative care

Indexed keywords

ANALGESIC AGENT; LOCAL ANESTHETIC AGENT; MORPHINE; OPIATE; PHENOL;

ADULT; AGED; ALCOHOLISM; ANESTHESIST; ARTICLE; BACKACHE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CONTROLLED STUDY; DELIRIUM; DETRUSOR DYSSYNERGIA; DRUG EFFICACY; DRUG SAFETY; FEMALE; GANGLION BLOCK; HEADACHE; HEALTH SERVICE; HUMAN; HYPOTENSION; INFECTION; INTERPERSONAL COMMUNICATION; JAPAN; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD REVIEW; MEDICAL SPECIALIST; MUSCLE WEAKNESS; NERVE BLOCK; NEUROLYSIS; PAIN ASSESSMENT; PHYSICIAN ATTITUDE; RATING SCALE; RESPIRATION DEPRESSION; STELLATE GANGLION BLOCK; SURVIVAL TIME; SYMPATHETIC BLOCKING;

COMORBIDITY; FEMALE; HUMANS; JAPAN; MALE; MEDICAL AUDIT; MIDDLE AGED; NEOPLASMS; NERVE BLOCK; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PALLIATIVE CARE; TREATMENT OUTCOME;

EID: 54249114870     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2007.11.009     Document Type: Article

References (20)

1. Ventafridda V., Tamburini M., Caraceni A., de Conno F., and Naldi F. A validation study of the WHO method for cancer pain relief. Cancer 59 (1987) 850-856
2. Hagan Q., Haddox J.D., Abram S., et al. Epidural opiates and local anaesthetic for the management of cancer pain. Pain 46 (1991) 271-279
3. Zech D.F.J., Grond S., Lynch J., Hertel D., and Lehman K.A. Validation of World Health Organisation guidelines for cancer pain relief: a 10-year prospective study. Pain 63 (1995) 65-76
4. Grond S., Zech D., Schug S.A., Lynch J., and Lehmann K.A. Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage 6 (1991) 411-422
5. Eisenberg E., Carr D.B., and Chalmers T.C. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg 80 (1995) 290-295
6. de Oliveira R., dos Reis M.P., and Prado W.A. The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain. Pain 110 (2004) 400-408
7. Wong G.Y., Schroeder D.R., Carns P.E., et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable. Pancreatic cancer. JAMA 291 (2004) 1092-1099
8. Mercadante S. Celiac plexus block versus analgesics in pancreatic cancer pain. Pain 52 (1993) 187-192
9. Kawamata M., Ishitani K., Ishikawa K., et al. Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain. Pain 64 (1996) 597-602
10. Mercadante S., Catala E., Arcuri E., and Casuccio A. Celiac plexus block for pancreatic cancer pain: factors influencing pain. Symptoms and quality of life. J Pain Symptom Manage 26 (2003) 1140-1147
11. Slatkin N.E., and Rhiner M. Phenol saddle blocks for intractable pain at end of life: report of four cases and literature review. Am J Hosp Palliat Care 20 (2003) 62-66
12. Hassenbusch S.J., Portenoy R.K., Cousins M., et al. Polyanalgesic consensus conference 2003: an update on the management of pain by intraspinal drug delivery-report of an expert panel. J Pain Symptom Manage 27 (2004) 540-563
13. Baker L., Lee M., Regnard C., Crack L., and Callin S. Evolving spinal analgesia practice in palliative care. Palliat Med 18 (2004) 507-515
14. Smith T.J., Staats P.S., Deer T., et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 20 (2002) 4040-4049
15. Smith T.J., and Coyne P. Implantable drug delivery systems (IDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients. J Palliat Med 8 (2005) 736-742
16. Miyashita M., Matoba K., Sasahara T., et al. Reliability and validity of the Japanese version of the Support Team Assessment Schedule (STAS-J). Palliat Support Care 2 (2004) 379-385
17. Morita T., Tusnoda J., Inoue S., Chihara S., and Oka K. Communication Capacity Scale and Agitation Distress Scale to measure the severity of delirium in terminally ill cancer patients: a validation study. Palliat Med 15 (2001) 197-206
18. Morita T., Tei Y., and Inoue S. Agitated terminal delirium and association with partial opioid substitution and hydration. J Palliat Med 6 (2003) 557-563
19. Morita T., Hyodo I., Yoshimi T., et al. Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies. Ann Oncol 16 (2005) 640-647
20. Hanks G.C.W., and Cherny N. Opioid analgesic therapy. In: Doyle D., Hanks G.C.W., and MacDonald N. (Eds). Oxford textbook of palliative medicine. 2nd edn (1998), Oxford Medical Publications, New York 331-355